Lielbritānija -
angļu -
MHRA (Medicines & Healthcare Products Regulatory Agency)
aricept evess 10mg orodispersible tablets
mawdsley-brooks & company ltd - donepezil hydrochloride - orodispersible tablet - 10mg
Lielbritānija -
angļu -
MHRA (Medicines & Healthcare Products Regulatory Agency)
aricept evess 10mg orodispersible tablets
sigma pharmaceuticals plc - donepezil hydrochloride - orodispersible tablet - 10mg
Lielbritānija -
angļu -
MHRA (Medicines & Healthcare Products Regulatory Agency)
aricept 10mg tablets
necessity supplies ltd - donepezil hydrochloride - oral tablet - 10mg
Lielbritānija -
angļu -
MHRA (Medicines & Healthcare Products Regulatory Agency)
aricept 5mg tablets
necessity supplies ltd - donepezil hydrochloride - oral tablet - 5mg
Lielbritānija -
angļu -
MHRA (Medicines & Healthcare Products Regulatory Agency)
aricept evess 10mg orodispersible tablets
de pharmaceuticals - donepezil hydrochloride - orodispersible tablet - 10mg
Lielbritānija -
angļu -
MHRA (Medicines & Healthcare Products Regulatory Agency)
aricept evess 10mg orodispersible tablets
lexon (uk) ltd - donepezil hydrochloride - orodispersible tablet - 10mg
Lielbritānija -
angļu -
MHRA (Medicines & Healthcare Products Regulatory Agency)
aricept evess 10mg orodispersible tablets
waymade healthcare plc - donepezil hydrochloride - orodispersible tablet - 10mg
Austrālija -
angļu -
Department of Health (Therapeutic Goods Administration)
aricept-d donepezil hydrochloride 10 mg tablet blister pack.
pfizer australia pty ltd - donepezil hydrochloride -
Austrālija -
angļu -
Department of Health (Therapeutic Goods Administration)
aricept-d donepezil hydrochloride 5 mg tablet blister pack.
pfizer australia pty ltd - donepezil hydrochloride -
Amerikas Savienotās Valstis -
angļu -
NLM (National Library of Medicine)
aricept- donepezil hydrochloride solution
eisai inc. - donepezil hydrochloride (unii: 3o2t2pj89d) (donepezil - unii:8ssc91326p) - solution - 1 mg in 1 ml - aricept® is indicated for the treatment of dementia of the alzheimer's type. efficacy has been demonstrated in patients with mild to moderate alzheimer's disease, as well as in patients with severe alzheimer's disease. aricept® is contraindicated in patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives.